Zinger Key Points
- Dogecoin and Shiba Inu suffer notable losses as Bitcoin dips below the $100,000 threshold.
- A trader highlights a sell signal for DOGE, while SHIB’s RSI of 66 suggests a slightly overbought condition.
Dogecoin DOGE/USD and Shiba Inu SHIB/USD are falling on Tuesday, as Bitcoin finds itself trading back below $98,000.
Cryptocurrency | Price | Market Cap | 24-Hour Trend | 7-Day Trend |
Dogecoin DOGE/USD | $0.3669 | $54.12 billion | -5.8% | +12.9% |
Shiba Inu SHIB/USD | $0.00002253 | $13.3 billion | -7.9% | +3.9% |
Pepe PEPE/USD | $0.00001906 | $8 billion | -9.8% | -10.4% |
Trader Notes: Crypto chart analyst Ali Martinez flagged a sell signal on DOGE’s daily chart, predicting a potential price correction.
More Crypto Online sees Dogecoin having dipped below upper micro support.
A drop to $0.30 is possible before a potential rally, which could present a buying opportunity.
Benzinga's technical analysis shows SHIB's Relative Strength Index (RSI) at 66.6, signaling strong bullish momentum but approaching overbought territory.
An RSI near 70 often hints at a possible correction as upward pressure wanes.
Statistics: IntoTheBlock data shows Shiba Inu large transaction volume spiking by 37.3% and transactions greater than $100,000 having increased from 82 to 113 in a single day.
Around 51% SHIB holders are in profit, 43% are underwater.
Shibariumscan data shows Shiba Inu's Layer-2 network maintaining over 4.7 million daily transactions since early 2025.
Shibburn reports a significant burn of 21.09 million SHIB in a single transaction.
Community News: Whale Alert data shows 1.64 trillion SHIB, worth $39 million, transferred from Crypto.Com to an unknown wallet.
A 70.08 million DOGE transfer, worth $27 million, was initiated on Jan. 7 by a mysterious whale from an unknown blockchain address.
The Shiba Inu community announced the impending launch of the TREAT token on Jan.14, promising to revolutionize the SHIB ecosystem.
Read Next:
Image: Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.